Abstract
In what looks like a bag-filling move, US company Bacterin International Holdings, Inc. a leader in the development of revolutionary bone graft material and antimicrobial coatings for medical applications, has signed an exclusive agreement with Jeil Medical Corporation for distribution in the U.S. and Canada of Jeil’s LeForte System.
Background
Bacterin develops, manufactures and markets biologics products to US and international markets. Bacterin’s proprietary methods optimize the growth factors in human allografts to create the ideal stem cell scaffold to promote bone, subchondral repair and dermal growth. These products are used in a variety of applications including enhancing fusion in spine surgery, relief of back pain, promotion of bone growth in foot and ankle surgery, promotion of cranial healing following neurosurgery and subchondral repair in knee and other joint surgeries.
The company’s Medical Device division develops, employs, and licenses bioactive coatings for various medical device applications. Bacterin’s strategic coating initiatives include antimicrobial coatings designed to inhibit biofilm formation and microbial contamination.
Procedure Expansion and Technology Partnering
The LeForte System is composed of orthopedic implants used in craniomaxillofacial procedures, including trauma and reconstruction, and complements Bacterin’s existing expertise and product offerings in the tissue grafting arena. Bacterin is planning to commence introduction of the LeForte System next month followed by a full product release during the second quarter of 2012.
Bacterin says the introduction of these products will expand its capabilities to include surgical procedures in the facial area, such as cranial and maxillofacial trauma, orthognathic surgery of the mid-face and mandible, mandibular reconstruction, reconstruction of the chin, and fracture fixation. Bacterin intends to develop a 2nd generation of the LeForte System to include its proprietary antimicrobial coating technology.
New VP for Bacterin
To support Bacterin’s expanding product portfolio, the company has promoted Nick Navarro to executive vice president of medical devices. Navarro has been with Bacterin more than two years, starting as a sales representative with rapid advancement to a regional vice president.
Navarro began his career with Johnson and Johnson focusing on wound closure. He was then recruited by Wright Medical, a global orthopaedic medical device company, where he became an extremity/foot and ankle specialist. It was in this role where his true passion for promoting hardware to surgeons was developed. Navarro looks forward to bringing his medical device expertise and detailed training style to the sales force and overseeing the launch of the Bacterin LeForte System.
Source: Bacterin
published: November 29, 2011 in: Contracts, ENT, Oral/Maxillofacial, People, Plastic/Reconstructive, Technology, Trauma, USA